This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krowchuck, D. P.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Krowchuck, D. P.
Related Collections
Right arrow Dermatology

AAP Grand Rounds 4:7 (2000)
© 2000 American Academy of Pediatrics

DERMATOLOGY

Steroid Rosacea in Prepubertal Children

Source: Weston WL, Morelli JG. Steroid rosacea in prepubertal children. Arch Pediatr Adolesc Med. 2000;154:62–64.

The first 20% of the full text of this article appears below.

To study the clinical features and response to treatment of perioral dermatitis resulting from topical steroid use (steroid rosacea), the authors retrospectively reviewed the records of 106 children (60 girls) less than 13 years of age with this condition seen at a University of Colorado dermatology clinic from 1991 to 1998. Age at onset, potency of topical steroid used, family history of rosacea, location of lesions, and treatment type and response were assessed. The mean age of onset was 7 years (range 6 months to 13 years) and a family history of rosacea . . . [Full Text of this Article]

Daniel P. Krowchuck, MD, FAAP
Pediatrics and Dermatology, Wake Forest University, Winston-Salem, NC